Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03592329 · ClinicalTrials.gov registry record · NA
Vagus Nerve Stimulation and Stress Reduction Training for Migraine
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
NCT03592329: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03592329 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 193 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03592329, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
Study Summary
This study design has two components: 1) a cross-sectional assessment of brain activity and inflammation in migraine patients compared to healthy controls and 2) an assessment of 8 weeks of a combination therapy approach to treating migraine.
Interventions
- DEVICE active tVNS
- DEVICE sham tVNS
- BEHAVIORAL Stress Reduction Training A
- BEHAVIORAL Stress Reduction Training B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2019-08-20 |
| Est. Completion | 2025-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03592329
The ClinicalTrials.gov registry entry for NCT03592329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which active tVNS is the first listed.
NCT03592329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03592329 about?
NCT03592329 is a clinical study titled "Vagus Nerve Stimulation and Stress Reduction Training for Migraine". This study design has two components: 1) a cross-sectional assessment of brain activity and inflammation in migraine patients compared to healthy controls and 2) an assessment of 8 weeks of a combination therapy approach to treating migraine.
What is the current status of trial NCT03592329?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2019-08-20. Estimated completion is 2025-05-29.
What interventions are being tested in trial NCT03592329?
The interventions under investigation include: active tVNS (DEVICE), sham tVNS (DEVICE), Stress Reduction Training A (BEHAVIORAL), Stress Reduction Training B (BEHAVIORAL).
Who is sponsoring clinical trial NCT03592329?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.